Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-30

Clinical Trial Update: Treatment With Indinavir and Chemotherapy for Advanced Classical Kaposi's Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluate indinavir in combination with chemotherapy for advanced classical Kaposi's Sarcoma; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Crixivan (indinavir)

Snippet

Sponsor: Barbara Ensoli, MD, PhD | Conditions: Kaposi's Sarcoma | Phase 2 | Status: COMPLETED